Another approval here!   

 

This time it is EU approval for Ranexa for chronic angina. Announced AH!  They will begin pricing negotiations with all 27 members and hope to sell in Europe next year.  EU patients use these drugs more than US patients. 

 

Its already approved and selling in the US.  They are also trying to get approval for other sub-cardio indications that are pending.

 

This company also recently got approval for Lexiscan-a contrast agent and did a big collaboration.

 

I doubled up a little while back and posted.  It really would be nice to see appeciable movement in this PPS based on all this news?   

 

Its up 6.58% in AH on really light volume-a surprise to the market?

 

AND YES!  Greedy this is that  stock you asked me about    and Cramer   said was going to be bought out over a year ago-I'm still in and Cramer is still a clown!    Will persistence pay off?

 

Kutz